We could not find any results for:
Make sure your spelling is correct or try broadening your search.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX... RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Show more
SOUTH SAN FRANCISCO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and c...
SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and c...
- RAPT to host a conference call today at 8:30 am ET - SOUTH SAN FRANCISCO, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biophar...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.11 | 1.33819951338 | 8.22 | 8.74 | 7.83 | 1203920 | 8.40653859 | CS |
4 | -0.14 | -1.65289256198 | 8.47 | 10.3731 | 6.86 | 2853894 | 8.73033955 | CS |
12 | -15.49 | -65.0293870697 | 23.82 | 27.35 | 6.86 | 1267738 | 12.09958128 | CS |
26 | -10.92 | -56.7272727273 | 19.25 | 27.35 | 6.86 | 803372 | 13.03003776 | CS |
52 | -10.81 | -56.4785788924 | 19.14 | 27.35 | 6.86 | 562453 | 14.91987418 | CS |
156 | -13.72 | -62.2222222222 | 22.05 | 43.26 | 6.86 | 453822 | 22.53459984 | CS |
260 | -3.92 | -32 | 12.25 | 51.2095 | 6.86 | 369408 | 22.76691816 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |